152 related articles for article (PubMed ID: 16805678)
1. Effect of EDTA root conditioning on the healing of intrabony defects treated with an enamel matrix protein derivative.
Sculean A; Berakdar M; Willershausen B; Arweiler NB; Becker J; Schwarz F
J Periodontol; 2006 Jul; 77(7):1167-72. PubMed ID: 16805678
[TBL] [Abstract][Full Text] [Related]
2. Healing of periodontal suprabony defects following treatment with open flap debridement with or without an enamel matrix derivative: A randomized controlled clinical study.
Iorio-Siciliano V; Blasi A; Stratul SI; Ramaglia L; Octavia V; Salvi GE; Sculean A
Clin Oral Investig; 2021 Mar; 25(3):1019-1027. PubMed ID: 32562077
[TBL] [Abstract][Full Text] [Related]
3. Autologous platelet concentrates for treating periodontal infrabony defects.
Del Fabbro M; Karanxha L; Panda S; Bucchi C; Nadathur Doraiswamy J; Sankari M; Ramamoorthi S; Varghese S; Taschieri S
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD011423. PubMed ID: 30484284
[TBL] [Abstract][Full Text] [Related]
4. The role of surgical flap design (minimally invasive flap vs. extended flap with papilla preservation) on the healing of intrabony defects treated with an enamel matrix derivative: a 12-month two-center randomized controlled clinical trial.
Windisch P; Iorio-Siciliano V; Palkovics D; Ramaglia L; Blasi A; Sculean A
Clin Oral Investig; 2022 Feb; 26(2):1811-1821. PubMed ID: 34491446
[TBL] [Abstract][Full Text] [Related]
5. Medium- and long-term clinical benefits of periodontal regenerative/reconstructive procedures in intrabony defects: Systematic review and network meta-analysis of randomized controlled clinical studies.
Stavropoulos A; Bertl K; Spineli LM; Sculean A; Cortellini P; Tonetti M
J Clin Periodontol; 2021 Mar; 48(3):410-430. PubMed ID: 33289191
[TBL] [Abstract][Full Text] [Related]
6. Use of platelet-rich fibrin for the treatment of periodontal intrabony defects: a systematic review and meta-analysis.
Miron RJ; Moraschini V; Fujioka-Kobayashi M; Zhang Y; Kawase T; Cosgarea R; Jepsen S; Bishara M; Canullo L; Shirakata Y; Gruber R; Ferenc D; Calasans-Maia MD; Wang HL; Sculean A
Clin Oral Investig; 2021 May; 25(5):2461-2478. PubMed ID: 33609186
[TBL] [Abstract][Full Text] [Related]
7. Healing of intrabony defects following regenerative surgery by means of single-flap approach in conjunction with either hyaluronic acid or an enamel matrix derivative: a 24-month randomized controlled clinical trial.
Pilloni A; Rojas MA; Marini L; Russo P; Shirakata Y; Sculean A; Iacono R
Clin Oral Investig; 2021 Aug; 25(8):5095-5107. PubMed ID: 33565017
[TBL] [Abstract][Full Text] [Related]
8. Apical approach in periodontal reconstructive surgery with enamel matrix derivate and enamel matrix derivate plus bone substitutes: a randomized, controlled clinical trial.
Moreno Rodríguez JA; Ortiz Ruiz AJ
Clin Oral Investig; 2022 Mar; 26(3):2793-2805. PubMed ID: 34791548
[TBL] [Abstract][Full Text] [Related]
9. Long-term clinical outcomes of periodontal regeneration with enamel matrix derivative: A retrospective cohort study with a mean follow-up of 10 years.
De Ry SP; Roccuzzo A; Lang NP; Sculean A; Salvi GE
J Periodontol; 2022 Apr; 93(4):548-559. PubMed ID: 34258767
[TBL] [Abstract][Full Text] [Related]
10. Two-year randomized clinical trial of enamel matrix derivative treated infrabony defects: radiographic analysis.
Ragghianti Zangrando MS; Chambrone D; Pasin IM; Conde MC; Pannuti CM; de Lima LA
BMC Oral Health; 2014 Dec; 14():149. PubMed ID: 25475143
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of a new-generation platelet-rich fibrin in the treatment of periodontal intrabony defects: a randomized clinical trial.
Csifó-Nagy BK; Sólyom E; Bognár VL; Nevelits A; Dőri F
BMC Oral Health; 2021 Nov; 21(1):580. PubMed ID: 34781955
[TBL] [Abstract][Full Text] [Related]
12. Healing of two-wall intra-bony defects treated with a novel EMD-liquid-A pre-clinical study in monkeys.
Shirakata Y; Miron RJ; Shinohara Y; Nakamura T; Sena K; Horai N; Bosshardt DD; Noguchi K; Sculean A
J Clin Periodontol; 2017 Dec; 44(12):1264-1273. PubMed ID: 28965367
[TBL] [Abstract][Full Text] [Related]
13. INTRABONY DEFECT TREATMENT WITH PLATELET-RICH FIBRIN, GUIDED TISSUE REGENERATION AND OPEN-FLAP DEBRIDEMENT: A RANDOMIZED CONTROLLED TRIAL.
Pham TAV
J Evid Based Dent Pract; 2021 Sep; 21(3):101545. PubMed ID: 34479673
[TBL] [Abstract][Full Text] [Related]
14. Dental root surface treatment with ethylenediaminetetraacetic acid does not improve enamel matrix derivative peptide treatment within intrabony defects: a retrospective study.
Bertoldi C; Labriola A; Generali L
J Biol Regul Homeost Agents; 2019; 33(6):1945-1947. PubMed ID: 31793282
[No Abstract] [Full Text] [Related]
15. Periodontal regenerative therapy with enamel matrix derivative in the treatment of intrabony defects: a prospective 2-year study.
Seshima F; Aoki H; Takeuchi T; Suzuki E; Irokawa D; Makino-Oi A; Sugito H; Tomita S; Saito A
BMC Res Notes; 2017 Jul; 10(1):256. PubMed ID: 28683765
[TBL] [Abstract][Full Text] [Related]
16. Dimensional evaluation of blood clot gap distances within intrabony defects following grafting and EDTA root surface treatment-experimental study in dogs.
Gamal AY; Abdel-Ghaffar KA; Zouair MG; Salama MH; El Destawy MT
J Periodontol; 2018 Jun; 89(6):691-698. PubMed ID: 29536543
[TBL] [Abstract][Full Text] [Related]
17. Autologous platelet concentrates for treating periodontal infrabony defects.
Fernando de Almeida Barros Mourão C
Evid Based Dent; 2019 Jun; 20(2):54-55. PubMed ID: 31253967
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of flapless intentional replantation with enamel matrix derivative in the treatment of hopeless teeth associated with endodontic-periodontal lesions: A 2-year prospective case series.
Saida H; Fukuba S; Miron R; Shirakata Y
Quintessence Int; 2018; 49(9):699-707. PubMed ID: 30027173
[TBL] [Abstract][Full Text] [Related]
19. Clinical efficacy of hyaluronic acid in the treatment of periodontal intrabony defect: a systematic review and meta-analysis.
Ostos-Aguilar BI; Pinheiro Furquim C; Muniz FWMG; Faveri M; Meza-Mauricio J
Clin Oral Investig; 2023 May; 27(5):1923-1935. PubMed ID: 36598601
[TBL] [Abstract][Full Text] [Related]
20. Long-term stability of adjunctive use of enamel matrix protein derivative on porcine-derived xenograft for the treatment of one-wall intrabony defects: A 4-year extended follow-up of a randomized controlled trial.
Lee JH; Jeong SN
J Periodontol; 2022 Feb; 93(2):229-236. PubMed ID: 34050681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
